Recent advances in the care of the patient with malignant melanoma. - Wikidata - wikimedia - TriplyDB

Recent advances in the care of the patient with malignant melanoma.

Recent advances in the care of the patient with malignant melanoma.

http://www.wikidata.org/entity/Q41317571

about

Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.The role of sentinel lymph node biopsy in the management of melanoma Lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma.Immunohistochemical detection of XIAP in melanoma.Accurate molecular detection of melanoma nodal metastases: an assessment of multimarker assay specificity, sensitivity, and detection rate.Evaluation of extensive initial staging procedure in intermediate/high-risk melanoma patients.Vital dye is enough for inguinal sentinel lymph node biopsy in melanoma patients.Sentinel Lymph Node Status is a Main Prognostic Parameter Needful for the Correct Staging of Patients with Melanoma Thicker than 4 mm: Single-Institution Experience and Literature Meta-Analysis.Is intra-operative gamma probe detection really necessary for inguinal sentinel lymph node biopsy?Sentinel lymph node biopsy in patients with thin melanomas.

P2860

Q30830061-53C23B1D-2303-4427-A606-5472396E18A7 Q34584396-C23FE683-E138-4896-8DDC-2E6555998AFE Q36532123-AE04F54B-929E-441D-9892-B3B366F6B512 Q38427860-4FA99A29-87C0-46BA-A6A8-B360E6B560E0 Q42937654-15E2CF27-4CD5-473C-9EAB-F67B85B98009 Q45222872-71090C38-13F5-4485-90CF-165C6BB8DB8F Q46954715-D048C42E-EF71-4A6E-ACED-64A761C6129E Q47744033-CF2353F6-BD1A-4373-8BA4-3C18DB695BDF Q50507748-CE87FB34-085E-4704-9A37-C37D1296394B Q53231420-B2EB9465-7436-4FF6-AEC0-F01C0C91C8EC

P2860

Recent advances in the care of the patient with malignant melanoma.

http://www.wikidata.org/entity/Q41317571

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Recent advances in the care of the patient with malignant melanoma.

@en

type

label

Recent advances in the care of the patient with malignant melanoma.

@en

prefLabel

Recent advances in the care of the patient with malignant melanoma.

@en

P1433

Q41317571-672097D8-C015-448E-9D24-85D341823A40

P1476

Q41317571-662BF8BD-A0AE-49F4-AD6E-D2BE8B928754

P2093

Q41317571-6F4ACB46-46A0-456B-8D95-E0536C31D5A6

Q41317571-7736DF31-52FC-4EA7-BDDB-B9E33DD0C0C6

Q41317571-8AF52831-F0D0-4DAC-9D6E-C4C054C6892E

Q41317571-C225FDA0-E725-4A62-A8DF-1A1AE809E8EF

P2860

Q41317571-023C0723-E9A9-4C06-8E02-8BEB9B466A34

Q41317571-04FF9B0C-EFC4-4040-8D74-089A36E7E1A9

Q41317571-0EFE6558-4700-40B1-BD8B-93DF0DF72FE4

Q41317571-2B18B8DD-D76B-42DF-A284-0DCB02B98730

Q41317571-35426D3D-08F5-46C7-A4A5-5540C97151DF

Q41317571-37FCFBAE-0BC5-490E-9BB2-FC23B97CFFA8

Q41317571-53BB3C11-FD2B-42BE-9D88-1E944F278D13

Q41317571-5C6B2BA7-71DC-4384-8EF3-A92E90BC298A

Q41317571-60B27445-2A47-4E4E-AB03-7CF9424ED4FE

Q41317571-65E333A9-694D-4CF1-B5A4-E87C33EECBF3

P304

Q41317571-7DAD7F1D-6B43-46F3-A9E3-3AC196664492

P31

Q41317571-71287224-80D5-4778-AA0C-8A9275EAC18A

P356

Q41317571-6969248F-6B12-4708-82ED-C643DA2B17AB

P407

Q41317571-95081FBF-6561-4605-B718-FF9924147640

P433

Q41317571-1EB3E870-0256-4CAA-BF42-20CAD05D28E8

P478

Q41317571-3B6D3256-DD73-4552-9DD8-686FE514935A

P577

Q41317571-611A060A-2CF7-47EB-984E-5BCBC7E3C4CB

P5875

Q41317571-D44DAE39-511E-4530-8C5E-019D8B9D39C4

P698

Q41317571-6BB398D7-D91B-4D25-95BA-612F004874DC

P932

Q41317571-6DF7747E-9D3A-4EBD-805D-FEE64FB625C2

P356

00000658-199701000-00001

P1433

Annals of Surgery

P1476

Recent advances in the care of the patient with malignant melanoma.

@en

P2093

C M Balch

http://www.w3.org/2001/XMLSchema#string

D Reintgen

http://www.w3.org/2001/XMLSchema#string

J Kirkwood

http://www.w3.org/2001/XMLSchema#string

M Ross

http://www.w3.org/2001/XMLSchema#string

P2860

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.

Minimal-access surgery for staging of malignant melanoma.

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

Age as a prognostic factor in the malignant melanoma population.

The role of elective lymph node dissection in melanoma: rationale, results, and controversies.

Lethal "thin" malignant melanoma. Identifying patients at risk.

Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma.

Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma.

Melanoma nodal metastases: biologic significance and therapeutic considerations.

P304

1-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00000658-199701000-00001

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

225

http://www.w3.org/2001/XMLSchema#string

P577

1997-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14210499

http://www.w3.org/2001/XMLSchema#string

P698

8998115

http://www.w3.org/2001/XMLSchema#string

P932

1190599

http://www.w3.org/2001/XMLSchema#string